About GH Paris Saint Joseph; Hopital De Jour Oncologie
L'hôpital Saint-Joseph est un hôpital généraliste privé situé dans le 14ᵉ arrondissement de Paris. Il appartient à la Fondation Hôpital Saint-Joseph qui gère plusieurs établissements privés sans but lucratif.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at GH Paris Saint Joseph; Hopital De Jour Oncologie
During the past decade, GH Paris Saint Joseph; Hopital De Jour Oncologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on
average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Tolerability Study of Claudiximab in Patients With Advanced Gastroesophageal Cancer
2009-05-01
2010-05-01
Completed
15
A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)
2011-07-06
2021-07-30
Completed
1,401
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
2011-12-20
2018-06-02
Completed
692
TKI and Interferon Alpha Evaluation Initiated by the German Chronic Myeloid Leukemia Study Group - the TIGER Study
2012-08-24
2022-05-31
Completed
717
A Combination Study of Kadcyla (Trastuzumab Emtansine) and Capecitabine in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (mBC) or HER2-Positive Locally Advanced/Metastatic Gastric Cancer (LA/mGC)
2012-12-03
2017-05-31
Terminated
182
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at GH Paris Saint Joseph; Hopital De Jour Oncologie
According to Clinical.Site data, the most researched conditions in "GH Paris Saint Joseph; Hopital De Jour Oncologie" are
"Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Ovarian Cancer" (1 trials) and "Prostate Cancer" (1 trials). Many other conditions were trialed in "GH Paris Saint Joseph; Hopital De Jour Oncologie" in a lesser frequency.
Clinical Trials Intervention Types at GH Paris Saint Joseph; Hopital De Jour Oncologie
Most popular intervention types in "GH Paris Saint Joseph; Hopital De Jour Oncologie" are "Drug" (4 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (3 trials), "Abiraterone" (1 trials), "Apitolisib" (1 trials), "Carboplatin" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at GH Paris Saint Joseph; Hopital De Jour Oncologie
The vast majority of trials in "GH Paris Saint Joseph; Hopital De Jour Oncologie" are
3 trials for "Female" genders, 2 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at GH Paris Saint Joseph; Hopital De Jour Oncologie
Currently, there are NaN active trials in "GH Paris Saint Joseph; Hopital De Jour Oncologie".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in GH Paris Saint Joseph; Hopital De Jour Oncologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in GH Paris Saint Joseph; Hopital De Jour Oncologie, 1 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".